Trial intelligence / Profile preview

Amnion vs Standard Care for Partial Thickness Burns

NCT00674999Phase 3Withdrawn

Sponsor
The University of Texas Medical Branch at Galveston
Start
Jun 2005
Primary completion
Sep 2008
Modality
Tissue Cells, Hydrogel Systems
01

Overview

Phase 3, randomised, open-label trial of biological amniotic membrane in partial-thickness burn (3 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Length of time to 95% healing of treated burn wounds. Planned start Jun 2005; status: withdrawn.

02

Drugs

biological amniotic membrane
03

Conditions

partial-thickness burn

Beyond the preview

Go deeper on NCT00674999.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00674999.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call